Tobramycin/Vancomycin Hydrochloride

妥布霉素/盐酸万古霉素

Report date: 2022/03/14 14:48:25
NMEQIDP

Base Information

Drug NameTobramycin/Vancomycin Hydrochloride
Drug Alias NameSBG-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitorsCell wall inhibitorsPeptidoglycan modulators
Targets30S ribosomal subunitPeptidoglycan
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes TobramycinVancomycin Hydrochloride
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A